Ascentage Pharma Group International (AAPG) Equity Ratio (2023 - 2025)

Ascentage Pharma Group International (AAPG) has 3 years of Equity Ratio data on file, last reported at 0.34 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio rose 233.54% year-over-year to 0.34; the trailing twelve-month figure through Dec 2025 stood at 0.11 (changed N/A YoY), and the FY2025 full-year result was 0.34, up 431438.72% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.34, up from 0.1 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.34 in Q4 2025 and bottomed at 0.03 in Q4 2023.
• The 3-year median for Equity Ratio is 0.1 (2024), against an average of 0.16.
• The widest annual swing landed in 2024, when Equity Ratio soared 257.27%; it then soared 233.54% in 2025.
• A 3-year view of Equity Ratio shows it stood at 0.03 in 2023, then jumped by 257.27% to 0.1 in 2024, then jumped by 233.54% to 0.34 in 2025.
• The last three Equity Ratio figures came in at 0.34 (Q4 2025), 0.1 (Q4 2024), and 0.03 (Q4 2023), per Business Quant data.

Peer Comparison